General Information
Xeris Hypothyroid XP-8121-120
A Phase 2, Multicenter, Non-Randomized, Open-Label, Single Arm, Self-controlled Study of XP-8121 For the Treatment of Adult Subjects with Hypothyroidism
| Protocol | XP-8121-120 |
|---|---|
| Identifier | |
| UID | b9bf5a56-4a9a-4a32-979f-f60c8f1f3857 |
| Status | Done - Archived |
| Phase | 2 |
| Category | Hypothyroid |
| Launch Year | 0 |
| NCT Number | - |
| Created | 2023-03-10 10:44 |
| Last Updated | 2024-05-02 17:01 |
Description
No description provided.
Comment
No comment.
Target Dates
| Name | Date | Required |
|---|---|---|
| Enrollment Closed | 2023-12-05 | No |
| Enrollment Open | 2023-04-18 | No |
| First Patient First Visit | No | |
| Site Initiation Mtg. | 2023-04-13 | No |
| PI Meeting Start | No | |
| PI Meeting End | No | |
| PI Meeting Arrival | No | |
| PI Meeting Departure | No | |
| Closeout Date | 2024-05-01 | No |
| Final PatientVisit | No | |
| PreStudy Selection Visit | No | |
| Target Date 12 | No | |
| Target Date 13 | No | |
| Target Date 14 | No |
Leadership
| Role | Staff | Login | Required |
|---|---|---|---|
| Principal | Mohseni, Rizwana | RMohseni | No |
| Recruiter | Gomez, Kathie | KGomez | No |
| Coordinator | Diaz-Chavez, Mayra | MDiaz-Chavez | No |
| Regulatory | Romero, Araselly | ARomero | No |
Custom Fields
No custom fields.
Sponsor & Organization
| Sponsor | Xeris Pharmaceuticals |
|---|---|
| Division | Xeris Pharmaceuticals |
| Team | Xeris Pharmaceuticals |
| Managing Site | Catalina Research Institute, LLC |
| Organization |
Contacts
| IRB Ref | |
|---|---|
| CRO | ProSciento, Inc. |
| CRO Ref | |
| Correspondence | 0 |
Opportunity
| Probability | 0 |
|---|---|
| Comment | |
| Status Color | Gainsboro |
| Currency | - |
